Patents Examined by Nancy A Treptow
-
Patent number: 10450593Abstract: This disclosure describes enzymes from the type II (a discrete set of enzymes) fatty acid synthesis (“FAS”) pathway that can be used in combination with thiolases to operate a functional reversal of the ?-oxidation cycle. A combination of thiolases with one or more of 3-oxoacyl-[acyl-carrier-protein] reductase (FabG, others), 3-hydroxyacyl-[acp] dehydratase (FabA, FabZ, others), and enoyl-[acyl-carrier-protein] reductase (FabI, FabK, FabL, FabV, others) yields a functional reversal of the ?-oxidation cycle. If only one or two enzymes are used, the remaining enzymes will be traditional beta oxidation enzymes. Once this cycle is coupled with the appropriate priming and termination pathways, the production of carboxylic acids, alcohols, hydrocarbons, amines and their ?-, ?-, and ?-functionalized derivatives from renewable carbon sources can be achieved.Type: GrantFiled: January 26, 2015Date of Patent: October 22, 2019Assignee: William Marsh Rice UniversityInventors: Ramon Gonzalez, James M. Clomburg, Jacob E. Vick
-
Patent number: 10435516Abstract: The present disclosure provides methods and compositions for directed to synthetic block copolymer proteins, expression constructs for their secretion, recombinant microorganisms for their production, and synthetic fibers (including advantageously, microfibers) comprising these proteins that recapitulate many properties of natural silk. The recombinant microorganisms can be used for the commercial production of silk-like fibers.Type: GrantFiled: April 4, 2018Date of Patent: October 8, 2019Assignee: Bolt Threads, Inc.Inventors: Daniel M. Widmaier, David N. Breslauer, Joshua Kittleson, Brendan Turner, Lindsay Wray
-
Patent number: 10428137Abstract: The present invention relates to a method for assembling (monomeric or oligomeric) proteins and peptide structures to multimeric protein or peptide structures. The present invention also provides a method for preparing peptide based polymers by crosslinking such multimeric proteins or peptides obtainable according to the inventive method and their use as polymers, for amphiphilic applications, as protein based detergents, for forming artificial organelles, etc. Disclosed are furthermore novel protein or peptide structures, nucleic acids encoding same and cloning and expression vectors suitable for carrying out the inventive method for assembling multimeric proteins or peptides.Type: GrantFiled: May 28, 2013Date of Patent: October 1, 2019Assignee: ALBERT-LUDWIGS-UNIVERSITAT FREIBURGInventors: Stefan Schiller, Matthias Huber
-
Patent number: 10428335Abstract: Disclosed are yeast cells expressing TAR DNA-binding protein 43 (TDP-43) and methods of screening yeast cells to identify compounds that prevent or suppress TDP-43-induced toxicity, compounds that inhibit the formation or maintenance of cytoplasmic inclusions of TDP-43, genetic suppressors or enhancers of TDP-43-induced toxicity, and genetic suppressors or enhancers of the formation or maintenance of cytoplasmic inclusions of TDP-43. Compounds identified by such screens can be used to treat or prevent TDP-43 proteinopathies such as frontotemporal lobar degeneration or amyotrophic lateral sclerosis.Type: GrantFiled: September 20, 2018Date of Patent: October 1, 2019Assignee: Whitehead Institute for Biomedical ResearchInventors: Susan L. Lindquist, Aaron D. Gitler
-
Patent number: 10385332Abstract: The present invention is based, at least in part, on the development of a mating-based yeast two-hybrid screen that allows simultaneous screening for mutations that disrupt yeast two-hybrid interactions between a protein and multiple interacting partners. By coupling PCR mutagenesis and homologous recombination/gapped plasmid repair with a mating-based assay, the present invention allows screening for unique mutations that disrupt interaction with one partner, but not others. It also allows identification of specific mutations that may lie at protein-protein interfaces common to two or more partners, without employing multiple rounds of screening. In addition to screening against multiple interacting partners, the present invention removes the need for a two-step selection because truncations, frameshifts, or any mutations that affect folding are eliminated as disruptions that affect all protein partners.Type: GrantFiled: February 1, 2016Date of Patent: August 20, 2019Assignee: The Johns Hopkins UniversityInventors: R. Blake Hill, Cara Marie Manlandro
-
Patent number: 10385397Abstract: Methods are provided for determining whether a subject has a graft tolerant phenotype. In practicing the subject methods, the expression level of one or more gene in a sample from the subject, e.g., a blood sample, is assayed to obtain a gene expression result, where the gene expression result includes a result for a biomarker of graft tolerance. The obtained gene expression result is then employed to determine whether the subject has a graft tolerant phenotype. Also provided are compositions, systems and kits that find use in practicing the subject methods. The methods and compositions find use in a variety of applications, including the determination of an immunosuppressive therapy regimen.Type: GrantFiled: February 9, 2016Date of Patent: August 20, 2019Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYInventors: Minnie M. Sarwal, Li Li
-
Patent number: 10377997Abstract: The present disclosure relates to the seminal discovery of a generation and use of genetically engineered Vibrio sp. Provided is the use of the genetically engineered bacteria for the construction, maintenance, manipulation, and/or propagation of DNA constructs; protein expression; protein secretion; vectors and other metabolic tools; metabolic engineering; expression of cellular extracts for cell-free biology; shuttle vectors; cloning vectors; and for synthetic biology applications. The disclosure also relates to the use of the replication machinery of Vibrio sp. as a cloning or expression vector for replication of recombinant DNA constructs. The disclosure also relates to methods of use of the above.Type: GrantFiled: December 1, 2016Date of Patent: August 13, 2019Assignee: Synthetic Genomics, Inc.Inventors: Matthew T Weinstock, Christopher M. Wilson, Eric D. Hesek
-
Patent number: 10370700Abstract: Provided herein are methods of detecting nucleic acids. The nucleic acid of interest may be detected by using Cas endonuclease to degrade substantially all nucleic acid in a sample except for the nucleic acid of interest, leaving the nucleic acid of interest isolated and amenable to detection. In related methods, Cas endonuclease complexes are used to protect the nucleic acid of interest while unprotected nucleic acid is digested, e.g., by exonuclease, after which the isolated nucleic acid of interest is detected.Type: GrantFiled: September 17, 2018Date of Patent: August 6, 2019Assignee: GENETICS RESEARCH, LLCInventors: Anthony P. Shuber, William Glover, Thomas C. Meyers
-
Patent number: 10365269Abstract: This disclosure describes a cell genetically modified to detect ribosome inhibition in the cell and methods involving such a cell. Generally, the genetically-modified cell includes an aminoglycoside-sensitive orthogonal 16S rRNA (O-16S) coding region bearing a mutated anti-Shine-Dalgarno (O-ASD) sequence, a repressor/operator system, and a polynucleotide encoding a detectable reporter under transcriptional control of the repressor/operator system. The repressor/operator system includes a coding region that encodes a transcriptional regulator and having an orthogonal SD (O-SD) sequence complementary to the 16S rRNA O-ASD sequence. The operator sequence, which is repressable by the transcriptional regulator, is operably linked to the polynucleotide encoding a detectable reporter.Type: GrantFiled: June 2, 2016Date of Patent: July 30, 2019Inventors: Charles Melancon, Shijie Huang
-
Patent number: 10358657Abstract: The present invention relates to methods and compositions for chromosome integration of nucleic acids into Deinococcus bacteria. The invention more particularly relates to IS-mediated multicopy gene insertion or chromosome engineering in Deinococcus bacteria, the resulting bacteria, and the uses thereof.Type: GrantFiled: December 19, 2014Date of Patent: July 23, 2019Assignee: DEINOVEInventors: Rémi Bernard, Esther Gerber, Elena Hauser, Jean-Paul Leonetti
-
Patent number: 10351861Abstract: The present invention relates to methods for constructing a recombinant fungal host cell comprising one or more copies of a polynucleotide construct integrated in its genome, said method comprising transforming a fungal host cell with an integrative polynucleotide construct comprising a first polynucleotide encoding a selectable marker, wherein the first polynucleotide, a 5? untranslated region thereof and/or a riboswitch operably linked therewith comprises a spliceosomal intron which has 5 nucleotides or less between its branch site and its acceptor site; and a second polynucleotide encoding a polypeptide of interest; as well as suitable polynucleotide constructs, resulting fungal host cells and methods of manufacture.Type: GrantFiled: October 18, 2016Date of Patent: July 16, 2019Assignee: Novozymes A/SInventor: Carsten Lillelund Olsen
-
Patent number: 10351863Abstract: The present invention relates to methods for constructing a recombinant fungal host cell comprising one or more copies of a polynucleotide construct integrated in its genome, said method comprising transforming a fungal host cell with an integrative polynucleotide construct comprising a first polynucleotide encoding a selectable marker, wherein the first polynucleotide, a 5? untranslated region thereof and/or a riboswitch operably linked therewith comprises a spliceosomal intron which has 5 nucleotides or less between its branch site and its acceptor site; and a second polynucleotide encoding a polypeptide of interest; as well as suitable polynucleotide constructs, resulting fungal host cells and methods of manufacture.Type: GrantFiled: June 26, 2018Date of Patent: July 16, 2019Assignee: Novozymes A/SInventor: Carsten Lillelund Olsen
-
Patent number: 10337019Abstract: Fungal artificial chromosome (FAC) vectors are disclosed. A vector can be replicated in a bacterial or a fungal host, and can comprise an insert of heterologous DNA up to about 500 kilobases. A vector can be used for cloning and expressing a secondary metabolite (SM) gene cluster. An insert sequence can be modified by homologous recombination. A vector can be a plasmid comprising bacterial and fungal origins of replication, as well as bacterial and fungal selection marker genes. Also disclosed are vectors that can be integrated into a fungal genome, and dual function vectors which can be replicated in a bacterial or a fungal host and can also be integrated into a fungal genome. Also disclosed are methods of generating plasmid libraries including vectors comprising intact SM gene clusters.Type: GrantFiled: April 29, 2016Date of Patent: July 2, 2019Assignee: INTACT GENOMICS, INC.Inventor: Chengcang Charles Wu
-
Patent number: 10336999Abstract: The disclosure provides compositions and methods for producing natural products in microorganisms that are otherwise unexpressed, poorly expressed or poorly transcribed. In particular aspects, the disclosure provides compositions and methods for activating a silent gene or gene cluster with a bacteriophage and/or Streptomyces Antibiotic Regulatory Protein (SARP) transcription factor.Type: GrantFiled: May 27, 2016Date of Patent: July 2, 2019Assignee: Zymergen Inc.Inventors: Oliver Liu, Jeffrey Hoon Kim
-
Patent number: 10337038Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modified microorganism produces fatty acyl-CoA intermediates via a malonyl-CoA dependent but malonyl-ACP independent mechanism.Type: GrantFiled: July 18, 2014Date of Patent: July 2, 2019Assignee: CARGILL, INCORPORATEDInventors: Michael Lynch, Michael Louie, Shelley Copley, Eileen Spindler, Brittany Prather, Matthew Lipscomb, Tanya Lipscomb, Hans Liao, Dave Hogsett, Ron Evans
-
Patent number: 10308978Abstract: Transposon nucleic acids comprising a transposon end sequence and a calibration sequence for DNA sequencing in the transposon end sequence. In one embodiment, the transposon end sequence is a Mu transposon end. A method for the generation of DNA fragmentation library based on a transposition reaction in the presence of a transposon end with the calibration sequence providing facilitated downstream handling of the produced DNA fragments, e.g., in the generation of sequencing templates.Type: GrantFiled: October 24, 2017Date of Patent: June 4, 2019Assignee: THERMO FISHER SCIENTIFIC BALTICS UABInventors: Ian Kavanagh, Laura-Leena Kiiskinen, Heli Haakana
-
Patent number: 10301634Abstract: A method of producing a protein of interest (POI) by culturing a recombinant eukaryotic cell line comprising an expression construct comprising a regulatable promoter and a nucleic acid molecule encoding a POI under the transcriptional control of said promoter, comprising the steps a) cultivating the cell line with a basal carbon source repressing the promoter, b) cultivating the cell line with a limited amount of a supplemental carbon source de-repressing the promoter to induce production of the POI at a transcription rate or at least 15% as compared to the native pGAP promoter, and c) producing and recovering the POI; and further an isolated regulatable promoter and a respective expression system.Type: GrantFiled: October 26, 2016Date of Patent: May 28, 2019Assignee: LONZA LTD.Inventors: Diethard Mattanovich, Brigitte Gasser, Michael Maurer, Roland Prielhofer, Joachim Klein, Jana Wenger
-
Patent number: 10301613Abstract: The present invention relates to kits and methods of modifying the prokaryotic genome a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas system that utilized one nicking Cas nuclease and crRNAs. The kid and methods delete or replace portions of the prokaryotic genome. In some embodiments, an entire gene or multiple genes may be deleted or replaced.Type: GrantFiled: September 9, 2016Date of Patent: May 28, 2019Assignee: Arizona Board of Regents on behalf of Arizona State UniversityInventors: Xiao Wang, Kylie Standage-Beier
-
Patent number: 10294481Abstract: Some aspects provide engineered microbes for glycolate production. Methods for microbe engineering and culturing are also provided herein. Such engineered microbes exhibit greatly enhanced capabilities for glycolate production.Type: GrantFiled: September 30, 2016Date of Patent: May 21, 2019Assignee: Massachusetts Institute of TechnologyInventors: Gregory Stephanopoulos, Zheng-Jun Li, Brian Pereira
-
Patent number: 10287591Abstract: The present invention relates in general to bacterial cells having a genetic alteration that results in increased expression of a protein of interest and methods of making and using such cells. Aspects of the present invention include Gram positive microorganisms, such as Bacillus species, having a genetic alteration that modifies activity of a protein encoded by the ykf operon and results in enhanced expression of a protein of interest.Type: GrantFiled: December 8, 2014Date of Patent: May 14, 2019Assignee: DANISCO US INCInventors: Cristina Bongiorni, Rei Otsuka, Brian F. Schmidt, Anita Van Kimmenade